CSTL Earnings

Quarterly EPS
$0.34
Q4 2024
$-0.90
Q1 2025
$0.16
Q2 2025
$-0.02
Q3 2025
$-0.08
Q4 2025
$-0.49
Q1 2026
$-0.07
Q2 2026
$-0.13
Q3 2026
Latest Revenue102.9M
Latest Net Income-4100000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.13102.9M-4100000+23.9%-550.0%
Q2 2026-$0.07103.5M-2060000+20.1%-143.8%
Q1 2026-$0.4983.7M-14522000-4.9%+45.6%
Q4 2025-$0.0887.0M-2332000+0.8%-123.5%
Q3 2025-$0.0283.0M-501000-3.2%-125.0%
Q2 2025$0.1686.2M4.5M-0.9%-50.0%
Q1 2025-$0.9088.0M-25848000+20.6%-900.0%
Q4 2024$0.3486.3M9.6M+30.5%+440.0%
Q3 2024$0.0885.8M2.3M——
Q2 2024$0.3287.0M8.9M——
Q1 2024-$0.0973.0M-2534000——
Q4 2023-$0.1066.1M-2580000——
Castle Biosciences (CSTL) — Earnings